129 related articles for article (PubMed ID: 10077737)
1. Identification of binding sites of bopindolol and its two metabolites with beta1-adrenoceptors by molecular modeling: comparison with beta2 adrenoceptors.
Hattori K; Ishiguro M; Ohnuki T; Nakamura T; Muramatsu I; Nagatomo T
Pharmacology; 1999 Apr; 58(4):183-9. PubMed ID: 10077737
[TBL] [Abstract][Full Text] [Related]
2. Studies on relationships between chemical structure and beta-blocking potency of bopindolol and its two metabolites.
Nagatomo T; Ishiguro M; Ohnuki T; Hattori K; Hosohata Y; Takatsu N; Katayama H; Watanabe K
Life Sci; 1998; 62(17-18):1597-600. PubMed ID: 9585142
[TBL] [Abstract][Full Text] [Related]
3. Beta-blocking potency and selectivity of bopindolol and its two metabolites for beta 1- and beta 2-adrenergic receptors as assessed by radioligand binding assay.
Sakuma N; Tsuchihashi H; Hosohata Y; Akashi H; Kinami J; Nagatomo T
J Pharmacobiodyn; 1991 May; 14(5):250-5. PubMed ID: 1685186
[TBL] [Abstract][Full Text] [Related]
4. Assessment of affinities of propranolol and bopindolol to membranes from COS-7 cell transiently transfected with beta-1- and beta-2-adrenoceptors using a radioligand-binding assay method.
Nakamura T; Suzuki A; Ohnuki T; Hattori K; Watanabe K; Kurose H; Nagao T; Nagatomo T
Pharmacology; 2000 Jul; 61(1):6-10. PubMed ID: 10895074
[TBL] [Abstract][Full Text] [Related]
5. GPCRs through the keyhole: the role of protein flexibility in ligand binding to β-adrenoceptors.
Emtage AL; Mistry SN; Fischer PM; Kellam B; Laughton CA
J Biomol Struct Dyn; 2017 Sep; 35(12):2604-2619. PubMed ID: 27532213
[TBL] [Abstract][Full Text] [Related]
6. The Isoleucine at Position 118 in Transmembrane 2 Is Responsible for the Selectivity of Xamoterol, Nebivolol, and ICI89406 for the Human
Lim VJY; Proudman RGW; Monteleone S; Kolb P; Baker JG
Mol Pharmacol; 2023 Feb; 103(2):89-99. PubMed ID: 36351797
[TBL] [Abstract][Full Text] [Related]
7. Divergent agonist selectivity in activating β1- and β2-adrenoceptors for G-protein and arrestin coupling.
Casella I; Ambrosio C; Grò MC; Molinari P; Costa T
Biochem J; 2011 Aug; 438(1):191-202. PubMed ID: 21561432
[TBL] [Abstract][Full Text] [Related]
8. Bopindolol is a slowly dissociating beta 1-adrenoceptor antagonist when compared to other beta-blockers.
Hosohata Y; Sasaki K; Shen Y; Hattori K; Suzuki J; Nagatomo T
Biol Pharm Bull; 1995 Aug; 18(8):1066-71. PubMed ID: 8535397
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of high-affinity 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene-labeled fluorescent ligands for human β-adrenoceptors.
Baker JG; Adams LA; Salchow K; Mistry SN; Middleton RJ; Hill SJ; Kellam B
J Med Chem; 2011 Oct; 54(19):6874-87. PubMed ID: 21870877
[TBL] [Abstract][Full Text] [Related]
10. Bopindolol: pharmacological basis and clinical implications.
Nagatomo T; Hosohata Y; Ohnuki T; Nakamura T; Hattori K; Suzuki J; Ishiguro M
Cardiovasc Drug Rev; 2001; 19(1):9-24. PubMed ID: 11314603
[TBL] [Abstract][Full Text] [Related]
11. Site-directed mutagenesis of the rat beta1-adrenoceptor. Involvement of Tyr356 (7.43) in (+/-)cyanopindolol but not (+/-)[125Iodo]cyanopindolol binding.
Rezmann-Vitti LA; Louis SN; Nero TL; Jackman GP; Machida CA; Louis WJ
Eur J Med Chem; 2004 Jul; 39(7):625-31. PubMed ID: 15236843
[TBL] [Abstract][Full Text] [Related]
12. Identification of key residues in transmembrane 4 responsible for the secondary, low-affinity conformation of the human β1-adrenoceptor.
Baker JG; Proudman RG; Hill SJ
Mol Pharmacol; 2014 May; 85(5):811-29. PubMed ID: 24608857
[TBL] [Abstract][Full Text] [Related]
13. Identification of binding sites of prazosin, tamsulosin and KMD-3213 with alpha(1)-adrenergic receptor subtypes by molecular modeling.
Ishiguro M; Futabayashi Y; Ohnuki T; Ahmed M; Muramatsu I; Nagatomo T
Life Sci; 2002 Oct; 71(21):2531-41. PubMed ID: 12270758
[TBL] [Abstract][Full Text] [Related]
14. Binding properties of beta-blockers at recombinant beta1-, beta2-, and beta3-adrenoceptors.
Schnabel P; Maack C; Mies F; Tyroller S; Scheer A; Böhm M
J Cardiovasc Pharmacol; 2000 Oct; 36(4):466-71. PubMed ID: 11026647
[TBL] [Abstract][Full Text] [Related]
15. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Baker JG
Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528
[TBL] [Abstract][Full Text] [Related]
16. β1-and β2-adrenoceptors in hippocampal CA3 region are required for long-term memory consolidation in rats.
Zheng J; Luo F; Guo NN; Cheng ZY; Li BM
Brain Res; 2015 Nov; 1627():109-18. PubMed ID: 26343545
[TBL] [Abstract][Full Text] [Related]
17. The third intracellular loop and the carboxyl terminus of beta2-adrenergic receptor confer spontaneous activity of the receptor.
Chakir K; Xiang Y; Yang D; Zhang SJ; Cheng H; Kobilka BK; Xiao RP
Mol Pharmacol; 2003 Nov; 64(5):1048-58. PubMed ID: 14573753
[TBL] [Abstract][Full Text] [Related]
18. Characterization of porcine beta1- and beta2-adrenergic receptors in heart, skeletal muscle, and adipose tissue, and the identification of an atypical beta-adrenergic binding site.
Sillence MN; Hooper J; Zhou GH; Liu Q; Munn KJ
J Anim Sci; 2005 Oct; 83(10):2339-48. PubMed ID: 16160045
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the densities of 5-HT4 receptors, beta 1- and beta 2-adrenoceptors in human atrium: functional implications.
Kaumann AJ; Lynham JA; Brown AM
Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):592-5. PubMed ID: 8740155
[TBL] [Abstract][Full Text] [Related]
20. [Modeling study of three-dimensional structure of human beta adrenoceptors and receptor-antagonists interactions].
Ohnuki T; Nagatomo T; Ishiguro M
Nihon Yakurigaku Zasshi; 1999 Oct; 114 Suppl 1():123P-126P. PubMed ID: 10629868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
